Authors:
FEDERICO M
CLO V
BURGIATELLI M
CAROTENUTO M
GOBBI PG
VALLISA D
LOMBARDO M
AVANZINI P
DIRENZO N
DINI D
BALDINI L
SILINGARDI V
Citation: M. Federico et al., EFFICACY OF 2 DIFFERENT PROMACE-CYTABOM DERIVED REGIMENS IN ADVANCED AGGRESSIVE NON-HODGKINS-LYMPHOMA - FINAL REPORT OF A MULTICENTER TRIALCONDUCTED BY GISL, Haematologica, 83(9), 1998, pp. 800-811
Authors:
GOBBI PG
PIERESCA C
GHIRARDELLI ML
DIRENZO N
FEDERICO M
MERIL F
IANNITTO E
PITINI V
GRIGNANI G
DONELLI A
CAROTENUTO M
SILINGARDI V
Citation: Pg. Gobbi et al., LONG-TERM RESULTS FROM MOPPEBVCAD CHEMOTHERAPY WITH OPTIONAL LIMITED RADIOTHERAPY IN ADVANCED HODGKINS-DISEASE, Blood, 91(8), 1998, pp. 2704-2712
Authors:
NADALI G
TAVECCHIA L
ZANOLIN E
BONFANTE V
VIVIANI S
CAMERINI E
MUSTO P
DIRENZO N
CAROTENUTO M
CHILOSI M
KRAMPERA M
PIZZOLO G
Citation: G. Nadali et al., SERUM LEVEL OF THE SOLUBLE FORM OF THE CD30 MOLECULE IDENTIFIES PATIENTS WITH HODGKINS-DISEASE AT HIGH-RISK OF UNFAVORABLE OUTCOME, Blood, 91(8), 1998, pp. 3011-3016
Authors:
BRUGIATELLI M
FEDERICO M
GOBBI P
DIRENZO N
VALLISA D
ANGRILLI F
COLOMBI M
ASCARI E
SILINGARDI V
AMADORI S
Citation: M. Brugiatelli et al., COMPARISON OF IDARUBICIN VS EPIDOXORUBICIN-CONTAINING PROMACE-CYTABOMREGIMENS IN UNTREATED AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) - FINAL RESULTS OF A MULTICENTER RANDOMIZED TRIAL OF THE ITALIAN LYMPHOMA STUDY-GROUP (GISL), Blood, 90(10), 1997, pp. 840-840
Authors:
GOBBI PG
PIERESCA C
FRASSOLDATI A
CAROTENUTO M
DIRENZO N
LASALA A
BERTE R
AVANZINI P
FEDERICO M
SILINGARDI V
ASCARI E
Citation: Pg. Gobbi et al., VINBLASTINE, BLEOMYCIN, AND METHOTREXATE CHEMOTHERAPY PLUS EXTENDED-FIELD RADIOTHERAPY IN EARLY, FAVORABLY PRESENTING, CLINICALLY STAGED HODGKINS PATIENTS - THE GRUPPO-ITALIANO-PER-LO-STUDIO-DEI-LINFOMI EXPERIENCE, Journal of clinical oncology, 14(2), 1996, pp. 527-533
Authors:
MOLICA S
LEVATO D
DIRENZO N
LASALA A
CAROTENUTO M
Citation: S. Molica et al., AN ALL-ORAL COMBINATION THERAPY IN CHRONIC LYMPHOCYTIC-LEUKEMIA INCLUDING THE ORAL IDARUBICIN, American journal of hematology, 52(3), 1996, pp. 235-236
Authors:
GRIGNANI G
BRUGIATELLI M
GOBBI PG
PIERESCA C
DIRENZO N
IANNITTO E
MOLICA S
SANTAGATI G
GINALDI L
CARACCIOLO F
SILINGARDI V
Citation: G. Grignani et al., INTERNATIONAL PROGNOSTIC INDEX (IPI) AND AGE-ADJUSTED IPI (AA-IPI) ARE IMPROVED BY TUMOR BURDEN (TD) EVALUATION, Blood, 88(10), 1996, pp. 905-905
Authors:
FEDERICO M
GOBBI PG
MORETTI G
AVANZINI P
DIRENZO N
CAVANNA L
ASCARI E
SILINGARDI V
Citation: M. Federico et al., EFFECTS OF THYMOSTIMULIN WITH COMBINATION CHEMOTHERAPY IN PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA, American journal of clinical oncology, 18(1), 1995, pp. 8-14
Authors:
MOLICA S
DATTILO A
MANNELLA A
LEVATO D
MUSTO P
DIRENZO N
LASALA A
CAROTENUTO M
Citation: S. Molica et al., SOLUBLE INTERCELLULAR-ADHESION MOLECULE-1 CORRELATES WITH MARKERS OF DISEASE-ACTIVITY IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Blood, 85(8), 1995, pp. 2280-2281
Citation: N. Direnzo, EPODOXORUBICIN VS IDARUBICIN CONTAINING REGIMENS IN INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - PRELIMINARY-RESULTS OF A MULTICENTRIC RANDOMIZED TRIAL (VOL 78, PG 306, 1993), Haematologica, 78(6), 1993, pp. 425-425